{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:06:45Z","timestamp":1761664005113,"version":"3.37.3"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227082","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T18:30:18Z","timestamp":1578335418000},"page":"e0227082","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country"],"prefix":"10.1371","volume":"15","author":[{"given":"Mariana Fernanda Rodrigues","family":"Nutini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9524-0629","authenticated-orcid":true,"given":"James","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Giron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Flavia Nacif Pinto Coelho","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor Massaki","family":"Kohiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3225-1819","authenticated-orcid":true,"given":"Michelle","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cecilia Araripe","family":"Sucupira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele Schwartz","family":"Benzaken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Abr\u00e3o","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Ha M.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8395-7304","authenticated-orcid":true,"given":"Ricardo Sobhie","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"issue":"60","key":"pone.0227082.ref001","article-title":"Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study","volume":"13","author":"LM Pereira","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"4","key":"pone.0227082.ref002","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group","volume":"30","author":"Y Benhamou","year":"1999","journal-title":"Hepatology"},{"issue":"6","key":"pone.0227082.ref003","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1053\/jhep.2001.29201","article-title":"The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study","volume":"34","author":"V Di Martino","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"pone.0227082.ref004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2005.07.006","article-title":"Slower fibrosis progression in HIV\/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy","volume":"44","author":"N Br\u00e4u","year":"2006","journal-title":"J Hepatol"},{"issue":"6","key":"pone.0227082.ref005","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.meegid.2009.07.011","article-title":"The Quasispecies Nature and Biological Implications of the Hepatitis C Virus","volume":"9","author":"SL Fishman","year":"2009","journal-title":"Infect Genet Evol"},{"issue":"5178","key":"pone.0227082.ref006","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1126\/science.7915856","article-title":"Reduced rate of disease development after HIV-2 infection as compared to HIV-1","volume":"265","author":"R Marlink","year":"1994","journal-title":"Science."},{"key":"pone.0227082.ref007","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1478-3231.2011.02684.x","article-title":"An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region","volume":"32","author":"T Nakano","year":"2012","journal-title":"Liver Int"},{"key":"pone.0227082.ref008","first-page":"1","article-title":"The origin of hepatitis C virus","volume":"369","author":"P Simmonds","year":"2013","journal-title":"Curr Top. Microbiol Immunol"},{"key":"pone.0227082.ref009","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1096-9071(199806)55:2<92::AID-JMV2>3.0.CO;2-I","article-title":"Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa","volume":"55","author":"D Jeannel","year":"1998","journal-title":"J Med Virol"},{"key":"pone.0227082.ref010","first-page":"7914","article-title":"Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana","volume":"77","author":"D Candotti","year":"2003","journal-title":"West Africa. J Virol"},{"issue":"Pt 9","key":"pone.0227082.ref011","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1099\/vir.0.19240-0","article-title":"Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon","volume":"84","author":"J Ndjomou","year":"2003","journal-title":"J Gen Virol"},{"issue":"1 Suppl","key":"pone.0227082.ref012","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"E Gower","year":"2014","journal-title":"J Hepatol"},{"key":"pone.0227082.ref013","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ijpara.2007.04.009","article-title":"Investigating the endemic transmission of the hepatitis C virus","volume":"37","author":"OG Pybus","year":"2007","journal-title":"Int J Parasitol"},{"key":"pone.0227082.ref014","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1258\/095646204322637182","article-title":"The global burden of disease attributable to contaminated injections given in health care settings","volume":"15","author":"AM Hauri","year":"2004","journal-title":"Int J STD AIDS"},{"key":"pone.0227082.ref015","doi-asserted-by":"crossref","first-page":"e1000198","DOI":"10.1371\/journal.pmed.1000198","article-title":"The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis","volume":"6","author":"G Magiorkinis","year":"2009","journal-title":"PLoS Med"},{"issue":"3","key":"pone.0227082.ref016","volume":"25","author":"DL Wyles","year":"2017","journal-title":"Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future Regimens"},{"issue":"2","key":"pone.0227082.ref017","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/hep.28467","article-title":"Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study","volume":"64","author":"P Kwo","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"pone.0227082.ref018","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.28422","article-title":"Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2)","volume":"64","author":"E Lawitz","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"pone.0227082.ref019","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.27726","article-title":"ALLY-3 Study Team. All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study","volume":"61","author":"DR Nelson","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"pone.0227082.ref020","first-page":"129","article-title":"Strategies for laboratory HIV testing: an examination of alternative approaches not requiring Western blot","volume":"72","author":"PA Sato","year":"1994","journal-title":"Bull World Health Organ"},{"issue":"Suppl 1","key":"pone.0227082.ref021","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.jcv.2013.08.032","article-title":"A multicenter performance evaluation of the DPP HIV-1\/2 assay for the detection of HIV antibodies in various HIV testing algorithms","volume":"58","author":"JM Cappello","year":"2013","journal-title":"J Clin Virol"},{"volume-title":"R: A language and environment for statistical computing","year":"2018","author":"R Core Team","key":"pone.0227082.ref022"},{"key":"pone.0227082.ref023","doi-asserted-by":"crossref","unstructured":"Wickham H. tidyverse: Easily Install and Load the 'Tidyverse'. R package version 1.2.1. https:\/\/CRAN.R-project.org\/package=tidyverse. 2017.","DOI":"10.32614\/CRAN.package.tidyverse"},{"key":"pone.0227082.ref024","unstructured":"Signorell A. Tools for descriptive statistics. R package version 0.99.25. https:\/\/cran.r-project.org\/package=DescTools, 2018"},{"key":"pone.0227082.ref025","unstructured":"Warnes GR, Bolker B, Lumley T, Johnson RC. Various R Programming Tools for Model Fitting. R package version 2.18.1. https:\/\/CRAN.R-project.org\/package=gmodels, 2018."},{"issue":"1","key":"pone.0227082.ref026","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"E Gower","year":"2014","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0227082.ref027","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1590\/S0100-879X2005000100007","article-title":"Geographic distribution of hepatitis C virus genotypes in Brazil","volume":"38","author":"S Campiotto","year":"2005","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"pone.0227082.ref028","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bjid.2015.06.010","article-title":"Phylogenetic analysis of the emergence of main hepatitis C virus subtypes in S\u00e3o Paulo, Brazil","volume":"19","author":"AS Nishiya","year":"2015","journal-title":"Braz J Infect Dis"},{"issue":"5","key":"pone.0227082.ref029","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00126334-200304150-00014","article-title":"Risk factors for incident HIV infection among anonymous HIV testing site clients in Santos, Brazil: 1996\u20131999","volume":"32","author":"K Alves","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0227082.ref030","article-title":"High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men","author":"DL Braun","year":"2018","journal-title":"Clin Infect Dis"},{"key":"pone.0227082.ref031","doi-asserted-by":"crossref","first-page":"ciz949","DOI":"10.1093\/cid\/ciz949","article-title":"Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: Current incidence rates compared with rates during the interferon era","author":"P Ingiliz","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0227082.ref032","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(00)80166-X","article-title":"Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3","volume":"33","author":"L Rubbia-Brandt","year":"2000","journal-title":"J Hepatol"},{"issue":"10","key":"pone.0227082.ref033","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1111\/j.1365-2893.2011.01441.x","article-title":"HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis","volume":"18","author":"G Nkontchou","year":"2011","journal-title":"J Viral Hepat"},{"issue":"1","key":"pone.0227082.ref034","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.27095","article-title":"HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV","volume":"60","author":"F Kanwal","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"pone.0227082.ref035","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/hep.22262","article-title":"A randomized, prospective trial of ribavirin 400 mg\/day versus 800 mg\/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3","volume":"47","author":"P Ferenci","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"pone.0227082.ref036","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jhep.2010.12.024","article-title":"Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C","volume":"55","author":"M Manns","year":"2011","journal-title":"J Hepatol"},{"issue":"3","key":"pone.0227082.ref037","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1053\/j.gastro.2011.05.046","article-title":"Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections","volume":"141","author":"GR Foster","year":"2011","journal-title":"Gastroenterology"},{"issue":"27","key":"pone.0227082.ref038","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis","volume":"373","author":"MP Curry","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"pone.0227082.ref039","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa0806104","article-title":"Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection","volume":"360","author":"JG McHutchison","year":"2009","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T20:16:31Z","timestamp":1722284191000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227082"}},"subtitle":[],"editor":[{"given":"Jason","family":"Blackard","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227082","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,1,6]]}}}